Enovix (NASDAQ:ENVX – Get Free Report) updated its second quarter 2026 earnings guidance on Wednesday. The company provided EPS guidance of -0.170–0.130 for the period, compared to the consensus EPS estimate of -0.160. The company issued revenue guidance of $8.0 million-$9.0 million, compared to the consensus revenue estimate of $8.5 million.
Analyst Upgrades and Downgrades
A number of research firms recently commented on ENVX. Weiss Ratings reissued a “sell (e+)” rating on shares of Enovix in a research report on Friday, April 10th. TD Cowen decreased their target price on shares of Enovix from $15.00 to $7.50 and set a “hold” rating for the company in a research report on Thursday, February 26th. Oppenheimer reissued an “outperform” rating on shares of Enovix in a research report on Thursday, February 26th. JPMorgan Chase & Co. cut shares of Enovix from a “neutral” rating to an “underweight” rating in a research report on Wednesday, May 6th. Finally, Craig Hallum decreased their target price on shares of Enovix from $16.00 to $10.00 and set a “buy” rating for the company in a research report on Thursday, February 26th. Six investment analysts have rated the stock with a Buy rating, two have given a Hold rating and two have issued a Sell rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of “Hold” and an average price target of $14.05.
Get Our Latest Stock Analysis on Enovix
Enovix Stock Performance
Enovix (NASDAQ:ENVX – Get Free Report) last issued its quarterly earnings results on Wednesday, May 13th. The company reported ($0.14) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.15) by $0.01. Enovix had a negative net margin of 492.57% and a negative return on equity of 64.29%. The business had revenue of $7.60 million for the quarter, compared to analyst estimates of $6.95 million. Enovix has set its Q2 2026 guidance at -0.170–0.130 EPS. On average, equities research analysts expect that Enovix will post -0.81 earnings per share for the current fiscal year.
Institutional Trading of Enovix
A number of hedge funds and other institutional investors have recently made changes to their positions in ENVX. Parallel Advisors LLC increased its stake in shares of Enovix by 51.9% in the third quarter. Parallel Advisors LLC now owns 3,926 shares of the company’s stock worth $39,000 after acquiring an additional 1,342 shares during the period. Mackenzie Financial Corp acquired a new stake in shares of Enovix in the fourth quarter worth $77,000. CIBC Asset Management Inc acquired a new stake in shares of Enovix in the fourth quarter worth $78,000. Wilmington Savings Fund Society FSB acquired a new stake in shares of Enovix in the third quarter worth $80,000. Finally, Cibc World Markets Corp acquired a new stake in shares of Enovix in the fourth quarter worth $82,000. Institutional investors and hedge funds own 50.92% of the company’s stock.
Enovix Company Profile
Enovix Corporation (NASDAQ: ENVX) develops and manufactures advanced lithium-ion battery cells with a patented three-dimensional silicon-anode architecture. The company’s core focus is on delivering high energy density, improved safety, and longer cycle life compared to conventional graphite-based cells. Enovix’s technology targets a range of applications, including consumer electronics, wearable devices, electric vehicles and stationary energy storage systems.
Founded in 2011 and headquartered in Fremont, California, Enovix has built pilot production capability and is scaling up manufacturing capacity to meet growing demand.
Further Reading
- Five stocks we like better than Enovix
- D-Wave Earnings Looked Weak, But Investors May Be Missing This
- Nebius Upside Expands as AI Feedback Loop Intensifies
- Insider Trades: Okta and Abbott See Buys, Micron Insiders Sell
- Plug Power Flips The Switch On Profitability
Receive News & Ratings for Enovix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Enovix and related companies with MarketBeat.com's FREE daily email newsletter.
